Clinical trials
9 active studies led by Perspectum, of 27 in all
Source: ClinicalTrials.gov, Studies with Perspectum (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Perspectum in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Perspectum or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
9 active studies led by Perspectum, of 27 in all
Source: ClinicalTrials.gov, Studies with Perspectum (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
11 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Studies Perspectum leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Perspectum or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Perspectum: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Perspectum is in.
Stories on the topics Perspectum works in.
2.6 billion adults are overweight. GLP-1 medicines are changing weight care, while most supplements lack…
Read
An estimated 936 million adults have obstructive sleep apnoea, and most are undiagnosed. CPAP machines, oral…
Read
WHO counts 830 million people with diabetes, and 59% of adults with diabetes took no medicine for it in 2022…
Read